Last reviewed · How we verify
NCT06744946
Thoracoscopic Talc Pleurodesis Versus Bleomycin -Tranxemic Acid Mixture Injection in Chest Tube in Malignant Pleural Effusion
Phase 4 trial testing thoracoscope in Malignant Pleural Effusions (Mpe)- Pleurodesis in 60 participants. Completed in 4 December 2024.
29 October 2024
Quick facts
| Lead sponsor | Mohamed Sabry |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 September 2024 |
| Primary completion | 29 October 2024 |
| Estimated completion | 4 December 2024 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- thoracoscope
Conditions studied
- Malignant Pleural Effusions (Mpe)- Pleurodesis — all drugs for Malignant Pleural Effusions (Mpe)- Pleurodesis →
- Pleurodesis — all drugs for Pleurodesis →
Sponsor
Mohamed Sabry
Who can join
18 and older, any sex, with Malignant Pleural Effusions (Mpe)- Pleurodesis or Pleurodesis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Comparing Two Methods to Treat Fluid Build-up in Chest for Cancer Patients:Talc Powder Surgery versus Chest Tube Medicine.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06744946
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Mohamed Sabry trials
Trials by the same sponsor.
- NCT06750744 — Predictors of Antimicrobial Resistance in the Respiratory Intensive Care Unit of Alexandria Main University Hospital · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06744946 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mohamed Sabry
- Last refreshed: 20 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06744946.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing